Literature DB >> 10565505

Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy.

G Sanacora1, G F Mason, D L Rothman, K L Behar, F Hyder, O A Petroff, R M Berman, D S Charney, J H Krystal.   

Abstract

BACKGROUND: Several lines of emerging evidence suggest that dysfunction of gamma-aminobutyric acid (GABA) systems is associated with major depression. However, investigation of this hypothesis is limited by difficulty obtaining noninvasive in vivo measures of brain GABA levels. In this study we used in vivo proton magnetic resonance spectroscopy to investigate the hypothesis that abnormalities in the GABA neurotransmitter system are associated with the neurobiologic processes of depression.
METHODS: The GABA levels were measured in the occipital cortex of medication-free depressed patients meeting DSM-IV criteria (n = 14) and healthy control subjects with no history of mental illness (n = 18) using a localized difference editing proton magnetic resonance spectroscopy protocol. An analysis of covariance was employed to examine the effects of depression, sex, and age.
RESULTS: The depressed patients demonstrated a highly significant (52%) reduction in occipital cortex GABA levels compared with the group of healthy subjects. While there were significant age and sex effects, there was no interaction of diagnosis with either age or sex.
CONCLUSION: This study provides the first evidence of abnormally low cortical GABA concentrations in the brains of depressed patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10565505     DOI: 10.1001/archpsyc.56.11.1043

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  198 in total

1.  Response to flumazenil in the late luteal phase and follicular phase of the menstrual cycle in healthy control females.

Authors:  Emily C Bell; Glen B Baker; Christina Poag; Francois Bellavance; Janisse Khudabux; Jean-Michel Le Mellédo
Journal:  Psychopharmacology (Berl)       Date:  2004-01-08       Impact factor: 4.530

Review 2.  GABA-based evaluation of neurologic conditions: MR spectroscopy.

Authors:  L M Levy; A J Degnan
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-19       Impact factor: 3.825

Review 3.  In vivo magnetic resonance spectroscopy of GABA: a methodological review.

Authors:  Nicolaas A J Puts; Richard A E Edden
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2011-06-12       Impact factor: 9.795

4.  The role of GABA in primary insomnia.

Authors:  David T Plante; J Eric Jensen; John W Winkelman
Journal:  Sleep       Date:  2012-06-01       Impact factor: 5.849

Review 5.  Pharmacogenetics of antidepressant response.

Authors:  Stefano Porcelli; Antonio Drago; Chiara Fabbri; Sara Gibiino; Raffaella Calati; Alessandro Serretti
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

6.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

7.  Depressive-like behavior in adolescents after maternal separation: sex differences, controllability, and GABA.

Authors:  Melanie P Leussis; Nadja Freund; Heather C Brenhouse; Britta S Thompson; Susan L Andersen
Journal:  Dev Neurosci       Date:  2012-07-06       Impact factor: 2.984

8.  Twenty-one-base-pair insertion polymorphism creates an enhancer element and potentiates SLC6A1 GABA transporter promoter activity.

Authors:  Rungnapa Hirunsatit; Elizabeth D George; Barbara K Lipska; Hani M Elwafi; Lisa Sander; Carolyn M Yrigollen; Joel Gelernter; Elena L Grigorenko; Jaakko Lappalainen; Shrikant Mane; Angus C Nairn; Joel E Kleinman; Arthur A Simen
Journal:  Pharmacogenet Genomics       Date:  2009-01       Impact factor: 2.089

9.  Prefrontal GABA levels in cocaine-dependent subjects increase with pramipexole and venlafaxine treatment.

Authors:  Chris C Streeter; John Hennen; Yong Ke; J Eric Jensen; Ofra Sarid-Segal; Leanne E Nassar; Clifford Knapp; Angela A Meyer; Tae Kwak; Perry F Renshaw; Domenic A Ciraulo
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

10.  Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies.

Authors:  Dorota Maciag; Jonathan Hughes; Gillian O'Dwyer; Yilianys Pride; Craig A Stockmeier; Gerard Sanacora; Grazyna Rajkowska
Journal:  Biol Psychiatry       Date:  2009-12-09       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.